Paediatric bloodstream infections: from neonates to children

17:15 • 3698 • Understanding community-acquired bloodstream infections in paediatric patients in a humanitarian hospital in Northwest Nigeria > A. Annick LENGLET (Amsterdam) 17:20 • 3511 • Challenges and strategies used in the implementation of a global multi-centre prospective observational cohort protocol to investigate aetiology and management of neonatal sepsis: the NeoOBS study > A. Amy RIDDELL (London) 17:25 • 3277 • Clinical presentation, prediction of mortality and development of the NeoSep severity score for neonates hospitalised with sepsis in low- and middle-income settings: analysis from the NeoOBS study > W. Wolfgang STOHR (London) 17:30 • 3342 • The complex relationship between timing of concordant antibiotic treatment, clinical severity, and mortality in neonates with carbapenem-resistant organism bloodstream infections from a multi-centre cohort study: the NeoOBS study > A. Aislinn COOK (London) 17:35 • 2894 • OptimiSation of the medical management of appendiceal mass and abscess in children: a 2009 to 2019 cohort study > L. Laily SADOZAI (Aulnay-Sous-Bois) 17:40 • 551 • Multi-centre, randomised controlled trial comparing an optimised dosing to a standard dosing regimen of vancomycin in the treatment of Gram-positive late-onset sepsis in infants up to 90 days of age: the NeoVanc trial identifies a potential safety signal > L. Louise Frances HILL (London) 17:45 • 1879 • Neonatal early-onset infections: the sensitivity of the early-onset sepsis calculator compared to the Dutch guideline > L. Linde SNOEK (Amsterdam) 17:50 • 3769 • Evidence of paediatric sepsis caused by a <em>Lactococcus garvieae</em>-contaminated platelet concentrate > L. Luna COLAGROSSI (Rome) 17:55 • 1810 • <em>Enterobacter cloacae </em>complex associated with neonatal sepsis, a retrospective multi-centre study in France > E. Enrique HERNANDEZ-ALONSO (Paris) 18:00 • 275 • Usefulness of routine microbiological screening results in choosing empiric antibiotics in neonatal sepsis > J. Jakob ARMANN (Dresden) 18:05 • INT2 • Q&A/Discussion